Share on StockTwits

Research analysts at Morgan Stanley lifted their price target on shares of Danaher (NYSE:DHR) from $84.00 to $85.00 in a report released on Thursday. Morgan Stanley’s target price would suggest a potential upside of 8.97% from the company’s current price.

Shares of Danaher (NYSE:DHR) traded down 0.37% on Thursday, hitting $78.00. 2,258,676 shares of the company’s stock traded hands. Danaher has a 1-year low of $64.78 and a 1-year high of $81.14. The stock has a 50-day moving average of $79.30 and a 200-day moving average of $76.24. The company has a market cap of $54.563 billion and a P/E ratio of 21.57.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, April 16th. The company reported $0.81 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.80 by $0.01. The company had revenue of $4.66 billion for the quarter, compared to the consensus estimate of $4.67 billion. During the same quarter last year, the company posted $0.75 earnings per share. Danaher’s revenue was up 4.9% compared to the same quarter last year. On average, analysts predict that Danaher will post $3.75 earnings per share for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Danaher in a research note on Friday, June 27th. They now have a $83.00 price target on the stock. Separately, analysts at Global Hunter Securities initiated coverage on shares of Danaher in a research note on Thursday, June 19th. They set a “buy” rating and a $41.00 price target on the stock. Finally, analysts at Citigroup Inc. upgraded shares of Danaher from a “focus list” rating to a “focus list” rating in a research note on Thursday, May 22nd. Four equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have given a strong buy rating to the company’s stock. Danaher has an average rating of “Buy” and a consensus target price of $74.07.

Danaher Corporation (NYSE:DHR) designs, manufactures and markets professional, medical, industrial and commercial products and services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.